News
First UK patient given GSK’s experimental arthritis drug in COVID-19 trial
A patient in Manchester is the first in the UK to be treated in a new COVID-19 trial investigating the use of an experimental arthritis drug, otilimab, for severe lung disease related to the novel coronavirus.